The PBMs are fighting a multi-front battle right now: patients, policymakers, states, and biopharma are all upset, and for good reason. But no one may be more mad than pharmacists, who laid out some of their issues in a compelling letter last week: ncpa.org/sites/default/…

Thank you to everyone who joined us at BIO's first Agriculture & Environment Summit. It was two days of important discussions about ways to advance our bioeconomy and support agricultural innovation and climate technology. We hope you will join us next year! #BIOSummit

President & CEO of @iambiotech John F. Crowley took the #StateofPossible24 stage to share his own experiences here in Boston (including a Henri Termeer story!), his perspective on coming to #biotech through his children’s diagnoses, and his agenda for BIO.

The FDA's accelerated approval has been, on balance, a hugely helpful regulatory approach for those with cancer.  steve usdin has an incredible piece laying out how recent attacks on the pathway misconstrued both the data and the FDA's work in the area. biocentury.com/article/652132

With its potential to expand the horizons of what’s possible for patients, CRISPR is the new darling of biotech. In this episode we talk with two companies working together on the next generation of CRISPR: editing cells within the body. 🧬🔬

Listen now: bio.org/podcast/editin…

From developing biodegradable materials to pioneering eco-friendly agricultural practices, biotechnology is driving innovation that not only provides benefits to human health but also safeguards our planet for future generations. Happy #EarthDay from all of us at BIO. 🌎🌱🔬

In the latest #IamBIO episode, hear how companies like United Therapeutics are addressing climate change through innovation—from carbon-neutral facilities to agricultural innovations that reduce greenhouse gas emissions.

🎧Listen now: bio.org/podcast/biotec…

This Health Affairs piece has an important reminder: even if list prices are cut under the IRA, payers may still have an incentive to push patients to more expensive medicines where they can mine greater profits. healthaffairs.org/content/forefr…

BIO is conducting a survey to improve communication between biotech firms and the FDA. This initiative aims to streamline the drug approval process, ensuring transparency and efficiency.

Learn more: bio.org/FDAsurvey

Nominations are open for BIO's Agriculture & Environment awards to recognize individuals who have made significant contributions to advance the bioeconomy and biotech innovation.

bio.org/george-washing…

bio.org/rosalind-frank…

I had a great discussion at the I Am Biotech Agriculture and Environment Summit today. The miracle of American innovation is inspiring. We must engage trade opportunities to increase market access, lower input costs, and protect American IP.

More highlights from BIO’s Agriculture & Environment Summit: Remarks from Chief Agricultural Trade Negotiator Amb. Doug McKalip, Rep. Adrian Smith, leading biotech companies, and more. #BIOSummit

Robust discussions at the #BIOSummit —including remarks from Rep. Deborah Ross, BIO President & CEO John Crowley, and panel discussions on national security, and regulatory issues. BIO is proud to host this event for biotech leaders who are moving our #bioeconomy forward.

BIO is proud to kick off our Agriculture & Environment Summit today—with discussions on the latest in plant, animal and microbial biotech to strengthen #foodsecurity and make our world more #sustainable . #BIOSummit

Thank you Congressman Gabe Amo for speaking with Patrice Milos Bolden Therapeutics & Carol Malysz today about boosting research into new treatments for patients. It was great to do this alongside other industry leaders and CSBA & @Iambiotech for the #BIOFLYIN24 ! Rhode Island Life Science Hub Brown University

At tomorrow’s BIO Agriculture & Environment Summit, Rep. Deborah Ross will share insights on how #biotech is contributing to the #cleanenergy transformation and creating #jobs in the growing #renewableenergy sector. #BIOSummit

Thank you Congressman Seth Magaziner for meeting with Patrice Milos Carol Malysz & Bolden Therapeutics in D.C. today to discuss supporting policies that fuel innovation in the #biotech industry. W/CSBA & @Iambiotech for #BIOFLYIN24 ! Rhode Island Life Science Hub Brown University

How can #biotech help us meet the challenges of #climatechange ? Tom Dower, Carleen Bowers and Tad Sonstegard will shed light on the answer tomorrow at BIO’s Agriculture & Environment Summit. #BIOSummit

Today, KLSC will speak with Rep. Brett Guthrie, Rep. James Comer, & Rep. Morgan McGarvey in D.C. about putting patients first and advancing policies that support innovation in #biotech . We're excited to do this with other industry leaders at the CSBA & @Iambiotech’s #BIOFLYIN24 .

Today, Carol Malysz will join CSBA & @Iambiotech in D.C. for #BIOFLYIN24 ! We will speak with members of Congress Congressman Gabe Amo Congressman Seth Magaziner Sheldon Whitehouse & Senator Jack Reed about supporting policies that fuel innovation in the #biotech industry. #RhodeIsland #LifeSciences